Q2FWI8 (MAZF_STAA8) Staphylococcus aureus (strain NCTC 8325 / PS 47)
Endoribonuclease MazF UniProtKBInterProSTRINGInteractive Modelling
120 aa; Sequence (Fasta) ;
12 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
14 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Staphylococcus aureus MazF in complex with Nanobody 12 |
Heteromer | 100 | 4×CL; 8×SO4; | |||
| Staphylococcus aureus MazF in complex with Nanobody 6 |
Heteromer | 100 | 5×CD; 1×PGE; 1×PG0; | |||
| Staphycoccus aureus MazF in complex with Nabobody 3 |
Heteromer | 100 | ||||
| Staphylococcus aureus MazF in complex with nanobody 5 |
Heteromer | 100 | 1×TRS; | |||
| Stapylococcus aureus MazF in complex with nanobody 10 |
Heteromer | 100 | 4×CL; | |||
| Staphylococcus aureus MazF in complex with Nanobody 9 |
Heteromer | 100 | 2×SO4; | |||
| Nanobody-mediated activation and inhibition of Staphylococcus aureus MazF |
Heteromer | 100 | 2×GOL; 1×CL; | |||
| Staphylococcus aureus MazF in complex with nanobody 4 |
Heteromer Q7A4G9; | 100 | 2×EPE; 2×MPO; | |||
| Structural and biophysical characterization of the mRNA interferase SaMazF from Staphylococcus aure… | homo-2-mer | 100 | ||||
| crystal structure of toxin from staphylococcus aureus Mu50 | homo-2-mer | 100 | ||||
| S. aureus MazF in complex with substrate analogue | homo-2-mer | 100 | 2×CL; | |||
| MazF from S. aureus crystal form I, P212121, 2.1 A | homo-2-mer | 100 | ||||
| MazF from S. aureus crystal form III, C2221, 2.7 A | homo-2-mer | 100 | ||||
| MazF from S. aureus crystal form II, C2221, 2.3 A | homo-2-mer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5dlo.1.B | homo-2-mer | 0.80 | 2×DA; | 100.00 | ||